Marshall Wace
PLXP

Marshall Wace’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Marshall Wace’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40,154
Closed -$98K – 3967
2022
Q2 		$98K Buy
+40,154
New +$112K ﹤0.01% 3280
2022
Q1 		– Sell
-11,084
Closed -$89K – 4288
2021
Q4 		$89K Sell
11,084
-45,444
-80% -$533K ﹤0.01% 3414
2021
Q3 		$1.09M Sell
56,528
-357,658
-86% -$6.25M ﹤0.01% 1964
2021
Q2 		$5.72M Buy
414,186
+148,724
+56% +$1.76M 0.03% 775
2021
Q1 		$2.4M Buy
+265,462
New +$1.94M 0.01% 1231

Other funds holding PLXP

Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
MSD Partners
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Steel Grove Capital Advisors
Steel Grove Capital Advisors Memphis, Tennessee $1.12B AUM 20.37% 1-Year Est. Return
Federation des caisses Desjardins du Quebec
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return

Marshall Wace's PLXP Position: Q3 2022 in Review

Marshall Wace sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2022, closing a stake of 40,154 shares — an estimated $98K sold.

Marshall Wace first reported a position in PLXP in Q1 2021 and held it in 5 quarters. The position peaked at $5.72M in Q2 2021. 40 funds tracked by Wall St. Rank hold PLXP as of Q3 2022.

  • Marshall Wace reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 40,154 PLx Pharma Inc. Common Stock shares in Q3 2022, an estimated $98K.
  • Marshall Wace first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Marshall Wace's PLx Pharma Inc. Common Stock position peaked at $5.72M in Q2 2021.
  • 40 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.